Pfizer Reports 80% Biosimilars Growth In Q3

Company Expects To Close Upjohn-Mylan Transaction In Q4

 
• By Akriti Seth
  
BusinessGraph
Pfizer has seen its biosimilars sales leap in Q3 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business